At a glance
ClinicalIndex Comparison RecordN/ACompleted· 220 enrolled
Drug / intervention
serum sampleother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
In Brief
An observational study evaluating serum sample for Lung Cancer and 2 related conditions. Completed, enrolled 220 participants across 1 site.
Detailed Summary
This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer, Biomarkers, Fatty Acids
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
First PostedSep 2012
Primary CompletionSep 2014
TodayJul 2026
First PostedSep 26, 2012
Enrollment StartAug 1, 2012
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 13.8 years ago
Interventions
serum sampleother
Serum samples from lung cancer patients were collected at the time of their diagnosis, prior to the initiation of treatment. Serum samples of control subjects were collected from a biobank